14 October 2026

Clinical research Men Pharmaceuticals

Tapering hair-loss drug resolves unwanted sexual symptoms

14 October 2026

Clinical research Dermatology Pharmaceuticals

GLP-1 drugs linked to nail changes

14 October 2026

Aged Care AIHW Pharmaceuticals

Polypharmacy hits 40% of over-75s

14 October 2026

Pharmaceuticals TGA

TGA fines individuals over medicine imports

30 September 2026

Pharmaceuticals psoriatic arthritis TGA

TGA nod expands PsA treatment options

2 September 2026

Clinical research Dermatology Paediatrics Pharmaceuticals

JAK inhibitors beneficial in paediatric AA

5 August 2026

Gastro PBS Pharmaceuticals

IBD patients caught in Australia’s medicines access gap

5 August 2026

Drugs Pharmaceuticals TGA

New guidance on peptide prescribing in the works

5 August 2026

Pharmaceuticals Research Vitiligo

Oral vitiligo drug clears phase 3 hurdle

22 July 2026

Guidelines Obesity Pharmaceuticals

ACP backs GLP-1s first for obesity

8 July 2026

Clinical research Diabetes Obesity Pharmaceuticals

Triple hormone receptor agonist improves glycaemic control and bodyweight reduction in T2D

10 June 2026

Acne Pharmaceuticals

Injectable testosterone linked to higher acne risk in transmasculine patients

10 June 2026

Diabetes Obesity Pharmaceuticals

How do people feel about using GLP-1 RAs?

13 May 2026

Pharmaceuticals TGA

Peptide craze sparks Lancet warning

29 April 2026

PBAC Pharmaceuticals

PBAC says yes to tirzepatide for T2D – but Lilly says no

29 April 2026

PBS Pharmaceuticals

Aussie-made hereditary angioedema therapy gains PBS listing